---
title: Radiation-induced morphea of the breast - characterization and treatment of
  fibroblast dysfunction with repurposed mesalazine
date: '2024-10-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39477958/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241031185340&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Radiation-induced morphea (RIM) is a rare complication of radiotherapy
  presenting as inflammatory fibrosis, most commonly reported in breast cancer patients.
  As underlying disease mechanisms are not well understood, targeted therapies are
  lacking. Since fibroblasts are the key mediators of all fibroproliferative diseases,
  this study aimed to characterize patient-derived fibroblasts to identify therapeutic
  targets. We studied primary human control and RIM-fibroblasts on a functional and
  ...
disable_comments: true
---
Radiation-induced morphea (RIM) is a rare complication of radiotherapy presenting as inflammatory fibrosis, most commonly reported in breast cancer patients. As underlying disease mechanisms are not well understood, targeted therapies are lacking. Since fibroblasts are the key mediators of all fibroproliferative diseases, this study aimed to characterize patient-derived fibroblasts to identify therapeutic targets. We studied primary human control and RIM-fibroblasts on a functional and ...